Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Materials Group (AMG) was a leading developer and manufacturer of high-performance specialty foam and flexible materials primarily serving the medical, electronics, and industrial markets. In the healthcare sector, the company specialized in medical-grade foams used for advanced wound care, patient positioning, and diagnostic components. AMG's expertise lay in the precision conversion and fabrication of technical materials to meet stringent medical standards. The company was a key supplier to major medical device OEMs before its acquisition by Boyd Corporation in 2013. Its legacy continues as part of Boyd's medical materials and thermal management portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Materials Group.